Work

Human Tumor Antigens and Cancer Immunotherapy

Year: 2015
Type: review
Abstract: With the recent developments of adoptive T cell therapies and the use of new monoclonal antibodies against the immune checkpoints, immunotherapy is at a turning point. Key players for the success of these therapies are the cytolytic T lymphocytes, which are a subset of T cells able to recognize and kill tumor cells. Here, I review the nature of the antigenic peptides recognized by these T cells and the processes involved in their presentation. I discuss the importance of understanding how each antigenic peptide is processed in the context of immunotherapy and vaccine delivery.
Language: English
Subfield: Immunology
Open Access status: hybrid
Estimated APC paid: $2,680
OpenAlex ID: W1784734551
FWCI: 2.032
Cites: 194
Cited by: 284
Related to: 9